CLBT Cellebrite DI Ltd. Annual reports only
Services-Prepackaged Software · Nasdaq · SEC CIK 1854587 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY18.6%
TTM net income YoY127.7%
TTM EPS YoY123.0%
Revenue 3-yr CAGR20.7%
Net income 3-yr CAGR-13.4%
Margins
Gross margin84.2%
Operating margin14.0%
Net margin16.5%
FCF margin33.7%
EBITDA margin16.5%
Returns
ROE19.1%
ROA9.6%
ROIC (approx.)22.8%
Asset turnover0.58x
Leverage & solvency
Liabilities / assets48.4%
Debt / equity0.00x
Current ratio1.56x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.22x
Accruals ratio-11.7%
Payout ratio—
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20222023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $475.68M | $401.20M | $325.11M | $270.65M | $246.25M |
| Cost of revenue | $75.17M | $62.59M | $53.23M | $50.75M | $42.56M |
| Gross profit | $400.50M | $338.61M | $271.88M | $219.91M | $203.69M |
| R&D expense | $113.88M | $98.42M | $84.39M | $80.62M | $65.54M |
| SG&A expense | $65.33M | $50.90M | $43.44M | $40.85M | $47.94M |
| Operating income | $66.48M | $56.91M | $33.24M | $1.04M | $13.82M |
| Pretax income | $90.68M | -$275.98M | -$75.56M | $120.76M | $82.31M |
| Income tax | $12.35M | $7.02M | $5.54M | -$45,000 | $10.91M |
| Net income | $78.33M | -$283.01M | -$81.10M | $120.81M | $71.40M |
| EBITDA | $78.35M | $67.51M | $43.25M | $10.24M | $20.83M |
| EPS (basic) | 0.32 | -1.35 | -0.43 | 0.64 | 0.49 |
| EPS (diluted) | 0.31 | -1.35 | -0.43 | 0.59 | 0.44 |
| Weighted avg. shares (diluted) | 249.90M | 209.47M | 190.15M | 195.39M | 161.54M |
| Balance sheet | |||||
| Cash & equivalents | $124.46M | $191.66M | $189.52M | $87.64M | $145.97M |
| Short-term investments | $151.54M | $101.82M | $38.69M | $44.64M | $0 |
| Receivables | $104.97M | $82.36M | $77.27M | $78.76M | $67.50M |
| Inventory | $7.60M | $8.94M | $9.94M | $10.18M | $6.51M |
| Current assets | $575.85M | $567.59M | $422.08M | $295.93M | $273.21M |
| PP&E, net | $22.21M | $17.00M | $15.90M | $17.26M | $16.76M |
| Goodwill | $119.56M | $28.71M | $26.83M | $26.83M | $26.83M |
| Intangibles | $81.47M | $11.31M | $10.59M | $11.25M | $11.23M |
| Total assets | $938.85M | $690.57M | $532.88M | $403.29M | $339.78M |
| Current liabilities | $369.66M | $295.50M | $253.82M | $207.78M | $186.57M |
| Total liabilities | $454.53M | $354.55M | $498.67M | $329.43M | $413.13M |
| Shareholders' equity | $484.32M | $336.02M | $34.21M | $73.86M | -$73.35M |
| Shares outstanding | 248.58M | 234.52M | 203.23M | 193.01M | 187.68M |
| Cash flow statement | |||||
| Operating cash flow | $173.54M | $132.17M | $102.06M | $20.58M | $36.05M |
| Capital expenditure | $13.22M | $8.57M | $5.23M | $6.90M | $5.11M |
| Free cash flow | $160.32M | $123.61M | $96.83M | $13.68M | $30.94M |
| Investing cash flow | -$268.25M | -$149.47M | -$22.54M | -$91.23M | $45.23M |
| Financing cash flow | $25.05M | $20.65M | $21.77M | $13.97M | -$68.40M |
| Depreciation & amortization | $11.87M | $10.61M | $10.01M | $9.19M | $7.01M |
| Stock-based compensation | $44.89M | $30.57M | $19.00M | $13.71M | $6.48M |
| Dividends paid | — | — | $0 | $0 | $100.00M |
| Share buybacks | — | — | — | $0 | $0 |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.